Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004954-99Phase 2Completed
Phase 2 trial of varenicline in alcohol dependence and nicotine dependence, sponsored by University of Gothenburg, Department of Psychiatry and Neurochemistry. Primary endpoint: Heavy drinking days during treatment vs baseline. Started Jun 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004954-99.